Illumina Stock Analysis (NASDAQ:ILMN)

Add to My Stocks
$172.75 $0.78 (0.45%) ILMN stock closing price Jul 21, 2017 (Closing)
Watch Robo Advisor Video of ILMN Stock Analysis
Illumina
Updated on : Jul 21, 2017
previous close
ILMN 172.8 (0%)
S&P 500 2472.5 (0%)
Closing Price On: Jul 21, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Biomed-Genetics
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q1
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
21.4%
Sector Average:
-0.5%
5 Quarter Net Profit
Net Margins
2017-Q1
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
1.25B
Debt/Equity Ratio:
 0.49
Compared to the industry
Cash Flow
Operating cash flow:
$168M
Net Income:
$372M
PROS      CONS
Operating Margins
Net Margins
ROIC
ROE
FCF Margin
High Debt Burden
Cash Flow
PE Valuation
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ILMN PS :
10.4
Industry PS :
5.2
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
17.5%
Return on Equity:
32.8%
Free Cash Flow Margin:
14.2%
Double Tap To Exit Full Screen
0:00
/

Illumina Analysis Video

501 6 2

View Illumina stock analysis video. This is our ILMN analyst opinion covering the buy and sell arguments for ILMN stock.

Illumina, Inc. Stock Rating (3.7/5)

Our Illumina stock opinion is based on fundamentals of the company. This Illumina stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ILMN stock?

  • Illumina's average operating margin of 21.4% was exceptional.
  • LTM Net margins were good at 30.7% for Illumina.
  • Illumina's return on invested capital of 17.5% is good.
  • The LTM ROE of 32.8% for Illumina is attractive.
  • Illumina has a healthy FCF (Free Cash Flow) margin of 14.2%.

Should you sell ILMN stock?

  • Illumina has a debt/equity ratio of  0.49, which is worse than the average in the Medical sector.
  • The company has an operating cash flow which is 0.5 times the net income. This is not a healthy sign.
  • The ILMN stock currently trades at a PE of 52, which is expensive, compared to the industry average of 24.4.

Comments on this video and Illumina stock